Advertisement
Evotec, Novo Nordisk Roll Out LAB EN To Accelerate Translation In Cardiometabolic Diseases
(RTTNews) - Evotec SE (EVO, EVOTF.PK) and Novo Nordisk A/S (NVO) announced Tuesday a translational drug discovery accelerator called LAB eN, which aims to nurture early research from academic institutions into novel therapeutics.
LAB eN is a unique engagement model that combines Evotec's multimodality drug discovery and pre-clinical development capabilities with Novo Nordisk's therapeutic, clinical, and commercial expertise.
LAB eN will focus on addressing unmet need in cardiometabolic diseases as well as rare blood and rare endocrine disorders.
LAB eN has already signed on four academic institutions to participate: Harvard University, Mass General Brigham, Yale University, and Beth Israel Deaconess Medical Center.
read more
Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook
Shares of Novo Nordisk A/S were gaining around 6 percent in Denmark as well as around 7 percent in the pre-market activity on the NYSE, after the Danish drug major reported Wednesday higher profit and sales in its first quarter, mainly reflecting improved results of its blockbuster weight loss drug Wegovy. Meanwhile, the company trimmed fiscal 2025 outlook for sales and operating profit growth...
RTTNews
|
5天前
Novo Nordisk Plans $4.1 Bln NC Facility To Boost Obesity Drug Supply
Danish drug maker Novo Nordisk announced its plans to invest $4.1 billion or about 27 billion Danish kroner to build a new manufacturing plant in Clayton, North Carolina with a view to expanding its manufacturing capacity in the United States. In the new plant, the company plans to produce current and future injectable treatments for people with obesity and other serious chronic diseases.
RTTNews
|
322天前
Novo Nordisk Says FLOW Trial Achieves Primary Endpoint
Novo Nordisk A/S (NVO) announced Tuesday the headline results from the kidney outcomes trial FLOW. The announcement follows the decision to stop the trial early due to efficacy.
RTTNews
|
433天前
Novo Nordisk Slashes US List Prices Of Several Insulin Products By Up To 75%
Healthcare company Novo Nordisk Inc. (NVO) announced Tuesday it is lowering the U.S. list prices of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes.
RTTNews
|
790天前
Australia NAB Business Confidence Rises, Conditions Fall
Australia business confidence improved in April, while conditions deteriorated due to weaker profitability, survey results from NAB showed on Tuesday. The business confidence index rose to -1 in April from -3 in March but remained negative. Confidence by industry was mixed, with a significant increase in confidence in manufacturing and smaller increases in wholesale, construction, and finance.
RTTNews
|
19分钟前
European Shares Seen Opening Mostly Lower Before US Inflation Data
European stocks are likely to open lower on Tuesday as investors await the U.S. Labour Department's April consumer price inflation data later in the day for more economic cues.
RTTNews
|
27分钟前
European Economic News Preview: UK Unemployment Data Due
Labor market statistics from the UK and economic sentiment from Germany are the top economic news due on Tuesday. At 2.00 am ET, the Office for National Statistics is scheduled to issue UK unemployment and wage data for the first quarter. The jobless rate is forecast to rise to 4.5 percent from 4.4 percent in the preceding period.
RTTNews
|
43分钟前
Sensex, Nifty Open Lower On Profit Taking After Rally
Indian shares were seeing some profit booking on Tuesday after a strong rally in the previous session.
RTTNews
|
1小时46分钟前
